Jiangsu Aidea Pharmaceutical Co Ltd (688488) — Capital Reinvestment Ratio
Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Capital Reinvestment Ratio of 0.51x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥3.56 Million) in capital expenditures (CN¥1.81 Million). See 688488 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Aidea Pharmaceutical Co Ltd Capital Reinvestment Ratio (2016–2020)
This chart tracks Jiangsu Aidea Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 3 annual periods. Check Jiangsu Aidea Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2020)
Year-by-year Capital Reinvestment Ratio for Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2020. For live market cap and broader valuation context, see Jiangsu Aidea Pharmaceutical Co Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.76x | CN¥56.17 Million | CN¥42.43 Million | ▲ +26.7% |
| 2019 | 0.60x | CN¥56.20 Million | CN¥33.50 Million | ▼ -73.7% |
| 2016 | 2.27x | CN¥31.29 Million | CN¥71.01 Million | — |